CSI Market
Sign In | Register

Sunshine Biopharma Inc (SBFM) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SBFM Annual Cash Flow →
Looking at cash flow data from Sunshine Biopharma Inc through Jun 30 2025 provides insight into Jun 30 2026's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-2.81
Depreciation & amortization0.15
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.87
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation0.10
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Stock Issued For Payment Interest-
Debt Conversion Converted Instrument Amount-
Loss On Conversion Of Notes Payable-
Stock Issued For Payment Interest On Notes Payable-
Debt Release-
Induced Conversion Of Convertible Debt Expense-
Current Income Tax Expense Benefit-
Increase Decrease In Operating Lease Liability-0.05
Goodwill And Intangible Asset Impairment-
Increase Decrease In Reduction In Rightofuse Asset0.05
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.70
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.61
Increase (Decrease) in Interest Payable, Net0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets-0.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.36
Discontinued operations0.00
Net Cash flow from Operating Activities-2.99
Investing Activities
Capital Expenditures-0.11
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Advances To Discontinued Operations-
Disposition Including Discontinued Operations Advances-
Cash Given From Acquisition-
Cash From Nora Pharma Acquisition-
Asset Disposition-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for Other Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Proceeds from Previous Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.11
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock7.80
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Increase (Decrease) in Deposits0.00
Other financing activities net0.00
Other net0.00
Note Payable Used To Pay Expenses-
Note Payable Used To Pay Origionation Fees-
Note Payable Used To Pay Origination Fees Interest-
Loan Processing Fee-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents9.12
Proceeds Public Offering Net-
Reduction In Lease Liability-
Purchase Of Treasury Stock-
Payment For Lease Liability-
Increase Decrease In Lease Liability-
Payments Of Lease Liability-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.80
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-3.10
Total Cash Flow4.70
4 historic quarters locked

Sign in to unlock the full Sunshine Biopharma Inc cash flow history.

Sign In Create Free Account

About Sunshine Biopharma Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001683168-26-006340

Figures are derived from filed reports and may be restated. Historical data is subject to revision.